Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

More On BIOCON.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Biocon Limited (BIOCON.NS)

-NSE
454.75 Down 2.45(0.54%) Apr 17, 5:59AM EDT
Get the big picture on all your investments.
Prev Close:457.20
Open:458.90
Bid:N/A
Ask:454.75
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:451.50 - 459.45
52wk Range:264.70 - 497.40
Volume:685,633
Avg Vol (3m):922,372
Market Cap:89.24B
P/E (ttm):16.38
EPS (ttm):27.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in INR.

Reports

  • No Reports available for BIOCON.NS at this time.

Key Statistics

Forward P/E (1 yr):19.01
P/S (ttm):3.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Mar-14) :20.37
Quarterly EPS Est (Mar-14) :N/A
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):1.87

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biocon Limited engages in the discovery, development, manufacture, and commercialization of biotechnology products in India and internationally. The company operates in two segments, Active Pharmaceutical Ingredients and Contract Research and Manu... View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback